LifeStance Health Group

Lifestance Health Group, Inc. provides outpatient mental health services. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. The firm operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. The company was founded by Michael K. Lester, Gwen H. Booth and Danish J. Qureshi in 2017 and is headquartered in Scottsdale, AZ.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

LifeStance Health Group reports strong Q4 performance and outlines growth strategies for 2023

LifeStance Health Group's Q4 2022 performance reflects financial stability and operational strength, meeting expectations.
The company's strategic focus on long-term profitability, clinician growth, and value-based care positions it for future success.
Challenges include consolidation efforts, payer contracting complexities, and transitioning to an integrated care model.
Opportunities for growth lie in collaboration with physical care providers, value-based care models, and data-driven approaches.

LifeStance Health Group exceeds Q1 expectations, eyes sustainable growth

LifeStance Health Group's Q1 2023 performance showcased strong financial results and operational advancements, driven by clinician growth and strategic initiatives.
While facing challenges such as clinician recruitment and margin progression, the company's focus on retention and value-based care initiatives bodes well for future growth.
With opportunities in clinician expansion, operational enhancements, and market adaptation, LifeStance Health Group is poised to capitalize on emerging trends and drive sustainable success.

LifeStance Health Group excels in Q2, eyes growth opportunities

LifeStance Health Group's Q2 2023 earnings call highlighted strong financial performance, operational improvements, and a strategic focus on enhancing patient care and value-based care arrangements. The company is navigating challenges in streamlining operations and adapting to regulatory changes while capitalizing on opportunities to drive growth and operational efficiencies.

LifeStance Health Group exceeds Q3 expectations, focuses on growth

LifeStance Health Group's Q3 2023 performance reflects strong revenue growth, operational improvements, and a focus on patient and clinician satisfaction.
While facing challenges such as negative free cash flow and ongoing legal actions, the company is poised for growth through revenue guidance increases and strategic investments.
Opportunities for revenue growth, clinician expansion, and enhanced patient experiences align with the company's commitment to quality care and financial performance.
CEO Ken Burdick's emphasis on exceeding expectations, raising guidance, and navigating legal challenges underscores the company's resilience and strategic direction.

LifeStance Health Group beats 2023 metrics, focuses on growth optimization

LifeStance Health Group's strong financial performance in 2023 reflects a focus on profitability, clinician growth, and patient experience, with plans for continued optimization.
Strategic investments in technology and operational processes position the company for future success, while challenges in moderating growth and improving funnel efficiency require attention.
Opportunities lie in enhancing patient acquisition and retention, clinician productivity, and operational efficiency, leveraging the company's early growth stage for scalability.
Management's commitment to a purpose-driven culture and operational excellence, supported by a dedicated team, underpins LifeStance Health Group's path to sustained success.

LifeStance Health Group excels in Q1 2024, eyes growth opportunities

LifeStance Health Group's Q1 2024 Earnings Call showcased robust financial performance, strategic resilience, and a focus on growth. While facing leadership transitions and short-term challenges, the company is poised for positive cash flow and continued improvements in revenue and margins.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Blue Safari Group Acquisition Corp

Kanzhun Ltd

1stdibs.com

Global Consumer Acquisition Corp

Janux Therapeutics

Logistics Innovation Technologies Corp

monday.com

Marqeta

TaskUS

Zeta Global Holdings Corp

Zhangmen Education

U.S. IPO Weekly Recap: Summer's First Wave Brings 10 IPOs

LifeStance Health plans to use part of its IPO proceeds to pay down debt, CEO Mike Lester said. The company aims to improve the mental health of consumers across the U.S.

LifeStance Health and Monday.com Stock Rise in First Day of Trading. What to Know.

Monday.com, LifeStance Health Group, and 1stdibs.com listed on the Nasdaq. Zeta Global Holdings picked the New York Stock Exchange.

Monday.com, 3 Other IPOs, Hit the Market

Monday.com, LifeStance Health Group, and 1stdibs.com are listed on the Nasdaq; Zeta Global Holdings picked the New York Stock Exchange.

4 Companies Begin Trading Today

SCOTTSDALE, Ariz., June 9, 2021 /PRNewswire/ -- LifeStance Health Group, Inc. ("LifeStance Health" or the "Company"), one of the nation's largest providers of outpatient mental health care, today announced the pricing of its initial public offering of 40,000,000 shares of its common stock at a public offering price of $18.00 per share.

LifeStance Health Group, Inc. Announces Pricing of Initial Public Offering

News for LifeStance Health Group Stock (LFST)